RECRUITING

Cognitive-Behavioral Therapy for Children With Nightmares

Talk to us

Conditions

NightmareSuicidal IdeationChildren, OnlyCBTCognitiveBehavioralTherapy

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to assess the efficacy of CBT-NC intervention to determine its impact on mental health and suicidality in children ages 6-17. The main aims are: Aim 1: Examine CBT-NC efficacy for improving nightmare distress and frequency in youth with chronic nightmares by comparing the treatment and waitlist group. Aim 2: Examine whether improvements in nightmares relate to fewer mental health problems for youth by determining by comparing the treatment and waitlist group.

Official Title

Can a Brief Therapy Improve Pediatric Nightmares, Mental Health, and Suicidality?

Quick Facts

Study Start:2023-08-07
Study Completion:2026-01-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06033781

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:6 Years to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Child must be between ages of 6-17 years 11 months.
  2. * Child must report recurrent nightmares that meet Diagnostic and Statistical Manual of Mental Disorders criteria for nightmare disorder.
  3. * Child must speak and understand English at no less than a 6-year-old level.
  4. * Children on prescribed psychotropic medications must be stable for 30 days prior to enrolling.
  5. * Child must have a parent or legal guardian attend study visits with them.
  6. * Participants must have access to WIFI/phone data in order to participate in this study and must have an electronic device with a camera enabled.
  1. * Children with a diagnosis of sleep apnea which is not adequately treated.
  2. * Children whose receptive/expressive language skills are below a 6-year-old level.
  3. * If it is determined that a child is actively suicidal and at imminent risk for self-harm, the family will be notified and referred for immediate care. They will not be eligible for the study until they are deemed stable.

Contacts and Locations

Study Contact

Lauren Prince, BA
CONTACT
918-634-3242
lauren-prince@ouhsc.edu

Principal Investigator

Lisa Cromer, PhD
PRINCIPAL_INVESTIGATOR
University of Tulsa
Tara Buck, MD
PRINCIPAL_INVESTIGATOR
University of Oklahoma

Study Locations (Sites)

University of Tulsa
Tulsa, Oklahoma, 74104
United States
University of Oklahoma School of Community Medicine
Tulsa, Oklahoma, 74135
United States

Collaborators and Investigators

Sponsor: University of Oklahoma

  • Lisa Cromer, PhD, PRINCIPAL_INVESTIGATOR, University of Tulsa
  • Tara Buck, MD, PRINCIPAL_INVESTIGATOR, University of Oklahoma

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-08-07
Study Completion Date2026-01-01

Study Record Updates

Study Start Date2023-08-07
Study Completion Date2026-01-01

Terms related to this study

Keywords Provided by Researchers

  • CBT
  • Cognitive
  • Behavioral
  • Therapy

Additional Relevant MeSH Terms

  • Nightmare
  • Suicidal Ideation
  • Children, Only